![Barry Quart](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Barry Quart
Chief Executive Officer at
CONNECT BIOPHARMA HOLDINGS LIMITED
Net worth: 1 M $ as of 31/05/2026
Profile
Barry D.
Quart was the founder of Ardea Biosciences, Inc., founded in 2006, where the titles held included President, Chief Executive Officer & Director from 2012 to 2013.
Current jobs include Chief Executive Officer & Director at Connect Biopharma Holdings Ltd. starting in 2024; Director at NeuroGenetic Pharmaceuticals, Inc.; Independent Director at Kiniksa Pharmaceuticals Ltd. since 2015; Director at Kiniksa Pharmaceuticals Corp.; and Independent Director at Kiniksa Pharmaceuticals International Plc starting in 2024.
Former jobs include Chairman & Chief Executive Officer at Heron Therapeutics, Inc. from 2020 to 2023; Director at Trimeris, Inc. from 2007 to 2011; Director, SVP-Global Research & Development at Pfizer (La Jolla); Independent Director at Synageva BioPharma Corp.
from 2012 to 2015; President-Research & Development at Agouron Pharmaceuticals LLC; Senior VP-Pfizer Global Research & Development at Pfizer Inc.; and President at Napo Pharmaceuticals, Inc. from 2002 to 2006.
Education includes a doctorate from The University of California, San Francisco.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.03% | 29/05/2026 | 15,345 ( 0.03% ) | 742 391 $ | 31/05/2026 |
| 16/03/2026 | 224,034 ( 0.4% ) | 557 845 $ | 31/05/2026 |
Barry Quart active positions
| Companies | Position | Start |
|---|---|---|
| CONNECT BIOPHARMA HOLDINGS LIMITED | Chief Executive Officer | 12/06/2024 |
NeuroGenetic Pharmaceuticals, Inc.
 NeuroGenetic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the prevention of neurodegenerative conditions | Director/Board Member | - |
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Director/Board Member | 01/10/2015 |
Kiniksa Pharmaceuticals Corp.
 Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes therapeutic medicines for patients suffering from debilitating diseases | Director/Board Member | - |
Former positions of Barry Quart
| Companies | Position | End |
|---|---|---|
| HERON THERAPEUTICS, INC. | Chief Executive Officer | 03/04/2023 |
| SYNAGEVA BIOPHARMA CORP | Director/Board Member | 22/06/2015 |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Founder | 01/05/2013 |
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for viral diseases | Director/Board Member | 04/11/2011 |
Napo Pharmaceuticals, Inc.
 Napo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets human gastrointestinal pharmaceuticals | President | 01/12/2006 |
Training of Barry Quart
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
60
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Heron Therapeutics, Inc.
 Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and distributes therapeutic products | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for viral diseases | Health Technology |
Napo Pharmaceuticals, Inc.
Napo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets human gastrointestinal pharmaceuticals | Health Technology |
NeuroGenetic Pharmaceuticals, Inc.
NeuroGenetic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the prevention of neurodegenerative conditions | Health Technology |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Health Technology |
Pfizer (La Jolla)
 Pfizer (La Jolla) Miscellaneous Commercial ServicesCommercial Services Provides research services | Commercial Services |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
Kiniksa Pharmaceuticals Corp.
Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes therapeutic medicines for patients suffering from debilitating diseases | Health Technology |
Connect Biopharma Holdings Ltd.
 Connect Biopharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
- Stock Market
- Insiders
- Barry Quart
